(Q50571579)

English

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. (English)

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

0 references

0 references

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

Jian-Wu Yu

1

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Gui-Qiang Wang

2

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Li-Jie Sun

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Xiao-Guang Li

4

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Shu-Chen Li

5

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

publication date

1 June 2007

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

22

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

832-836

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

6

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04904.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2007.04904.X

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/17565637

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50571579&oldid=2079565195"